Sjogren's Syndrome News and Research

RSS
Sjogren's syndrome is a chronic autoimmune syndrome characterized by lymphocyte infiltration of salivary glands, resulting in symptomatic eye and mouth dryness. Sjogren's syndrome can be associated with extraglandular presentations, such as musculoskeletal features including fatigue and fibromyalgia, in nearly 50% of patients, and fewer patients complain of arthralgias. According to the Sjogren's Syndrome Foundation, the condition affects approximately two million to four million Americans, mostly middle-age women.
Varied diets may be the cause for differences in human and non-human primate saliva

Varied diets may be the cause for differences in human and non-human primate saliva

Early clinical trial of new treatment for severe dry eye disease shows promising results

Early clinical trial of new treatment for severe dry eye disease shows promising results

The high cost of sex: Insurers often don’t pay for drugs to treat problems

The high cost of sex: Insurers often don’t pay for drugs to treat problems

OU researcher and collaborators are developing new strategies for early intervention of Lupus

OU researcher and collaborators are developing new strategies for early intervention of Lupus

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Scientists succeed in growing functional salivary gland

Scientists succeed in growing functional salivary gland

Silicone breast implants may increase risk of rare adverse outcomes in women

Silicone breast implants may increase risk of rare adverse outcomes in women

Patients with rheumatologic disease can safely receive life-saving cancer immunotherapy

Patients with rheumatologic disease can safely receive life-saving cancer immunotherapy

TSRI researchers find potential way to treat aqueous deficiency dry eye

TSRI researchers find potential way to treat aqueous deficiency dry eye

Two new studies find potential genetic cause and new treatment method for autoimmune diseases

Two new studies find potential genetic cause and new treatment method for autoimmune diseases

Virus-like elements within human genome linked to development of lupus and Sjogren's syndrome

Virus-like elements within human genome linked to development of lupus and Sjogren's syndrome

Taking ipilimumab, nivolumab drugs may increase risk of developing rheumatologic diseases

Taking ipilimumab, nivolumab drugs may increase risk of developing rheumatologic diseases

New study links cathepsin S protein to tear secretion in Sjogren's syndrome patients

New study links cathepsin S protein to tear secretion in Sjogren's syndrome patients

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

Inova Diagnostics announces FDA clearance for QUANTA Flash assays, QUANTA Flash Beta-2GP1 Domain1

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Nicox launches expanded access to Sequenom Laboratories' RetnaGene portfolio

Nicox launches expanded access to Sequenom Laboratories' RetnaGene portfolio

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

AARDA launches autoimmune curriculum for teachers of grades three through eight

AARDA launches autoimmune curriculum for teachers of grades three through eight

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases